Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach
24 May 2023, Israel: Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on
Read More
Evogene
Evogene Reports First Quarter 2023 Financial Results
19 May 2023, Israel: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing
Read More
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation & Drought Tolerance
10 May 2023, Israel: The Ag-Seed Division of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN)(“Evogene”), a leading computational biology company targeting to revolutionize
Read More
Plantis Licenses Two of Canonic’s Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market
03 May 2023, Israel: Canonic Ltd. (“Canonic”), focused on the development of medical grade cannabis products and a wholly owned subsidiary of
Read More
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
28 April 2023, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN,
Read More
Evogene Reports Fourth Quarter and Full Year 2022 Financial Results
10 March 2023, Israel: Evogene Ltd., a leading computational biology company targeting to revolutionize life-science based product discovery and development utilizing cutting
Read More
Lavie Bio Reports Successful Results for its Bio-Fungicides Programs
01 March 2023, Israel: Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing
Read More
Evogene Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
28 February 2023, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development announced today
Read More
Canonic Successfully Launched Six Second-Generation Cannabis Products with Higher THC and Rich Terpene Profiles
24 February 2023, Israel: Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene
Read More
Casterra Announces Agreement with World Leading Energy Company to Cultivate its Castor Varieties at Commercial Scale
19 January 2023, Israel: Casterra Ag Ltd. (“Casterra”), the integrated castor cultivation solution company and a subsidiary of Evogene Ltd. (“Evogene”) (Nasdaq:
Read More